PELIZZARI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 2.556
AS - Asia 1.119
EU - Europa 595
SA - Sud America 142
AF - Africa 24
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.439
Nazione #
US - Stati Uniti d'America 2.515
SG - Singapore 566
CN - Cina 211
BR - Brasile 117
VN - Vietnam 115
HK - Hong Kong 109
IT - Italia 99
DE - Germania 93
RU - Federazione Russa 80
UA - Ucraina 67
GB - Regno Unito 50
IN - India 37
FI - Finlandia 31
IE - Irlanda 31
CA - Canada 28
BE - Belgio 25
PL - Polonia 19
SE - Svezia 16
TR - Turchia 15
FR - Francia 14
BD - Bangladesh 13
AT - Austria 12
ES - Italia 12
JP - Giappone 11
AR - Argentina 10
NL - Olanda 10
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
KR - Corea 8
IR - Iran 7
MX - Messico 7
LT - Lituania 6
VE - Venezuela 6
ID - Indonesia 5
HU - Ungheria 4
IQ - Iraq 4
LV - Lettonia 4
MA - Marocco 4
RO - Romania 4
CO - Colombia 3
EC - Ecuador 3
IL - Israele 3
AL - Albania 2
BG - Bulgaria 2
EG - Egitto 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
PT - Portogallo 2
TG - Togo 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
LY - Libia 1
MM - Myanmar 1
MN - Mongolia 1
MZ - Mozambico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
YE - Yemen 1
ZW - Zimbabwe 1
Totale 4.439
Città #
Ashburn 367
Fairfield 262
Singapore 256
Chandler 227
Ann Arbor 138
Beijing 116
Woodbridge 111
Hong Kong 109
Houston 108
Seattle 103
Wilmington 84
Cambridge 82
New York 64
Los Angeles 53
Boardman 50
Dong Ket 41
Princeton 37
Jacksonville 35
Dearborn 34
Dublin 31
Munich 31
Brussels 25
San Diego 22
Dallas 21
Ho Chi Minh City 21
Buffalo 20
Hanoi 18
Montreal 18
Redmond 16
Warsaw 16
Redondo Beach 15
Chicago 14
Ogden 14
São Paulo 14
Helsinki 13
Izmir 13
Frankfurt am Main 12
Udine 12
Poplar 11
Tokyo 11
Turku 11
Des Moines 10
London 10
Washington 10
Brooklyn 9
Martignacco 9
Milan 9
Santa Clara 9
Chennai 8
Denver 8
Hefei 8
Düsseldorf 7
Leawood 7
Nuremberg 7
Seoul 7
Ardabil 6
Brno 6
Council Bluffs 6
Johannesburg 6
Orem 6
Stockholm 6
Toronto 6
Vienna 6
Augusta 5
Hải Dương 5
Lappeenranta 5
Lauterbourg 5
Newark 5
Norwalk 5
Phoenix 5
San Francisco 5
Trieste 5
Biên Hòa 4
Boston 4
Charlotte 4
City of London 4
Jinan 4
Manchester 4
Riga 4
Salt Lake City 4
San Jose 4
San Mateo 4
The Dalles 4
Amsterdam 3
Atlanta 3
Bari 3
Bắc Ninh 3
Caracas 3
Caserta 3
Contagem 3
Da Nang 3
Elk Grove Village 3
Guarulhos 3
Helena 3
Kunming 3
Miami 3
Nanjing 3
Nutley 3
Salvador 3
Scafati 3
Totale 2.962
Nome #
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 197
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 161
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 158
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 149
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 148
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy 143
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 135
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 132
Do platinum salts fit all triple negative breast cancers? 132
Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey 130
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 130
Atezolizumab for the treatment of breast cancer 126
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 125
Central nervous system involvement in breast cancer patients: Is the therapeutic landscape changing too slowly? 124
Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle 123
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer 123
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition 122
Hype or hope? The strange case of platinum salts’ renaissance in breast cancer 115
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 115
Lactate dehydrogenase as a prognostic biomarker in patients with hormone receptor-positive metastatic breast cancer treated with palbociclib: An exploratory cohort study 114
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients 114
Platinum Salts in Patients with Breast Cancer: A Focus on Predictive Factors 113
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 101
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic 99
Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation 99
Bevacizumab or PARP-Inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: A network meta-analysis 98
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 96
The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer 95
Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach 90
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 85
Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World 84
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 82
Non-small cell lung cancer harboring EGFR G724S mutation and exon 19 deletion responded to afatinib monotherapy after multiple lines of target therapies 78
T-DM1 versus pertuzumab, trastuzumab and a taxane as first-line therapy of early-relapsed HER2-positive metastatic breast cancer: an Italian multicenter observational study 74
Clinico-radiological monitoring strategies in patients with metastatic breast cancer: a real-world study 73
Prognostic role of visceral fat for overall survival in metastatic colorectal cancer: A pilot study 72
Alectinib for the treatment of papillary thyroid carcinoma harbouring STRN – ALK fusion 71
The Role of ctDNA in the Management of Non-Small-Cell Lung Cancer in the AI and NGS Era 60
An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: The ERA project 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 11 Medical and Health Sciences 1103 Clinical Sciences 59
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiota 53
Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase 50
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study 49
Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA) 42
Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future Perspectives 41
Totale 4.580
Categoria #
all - tutte 19.187
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.187


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021315 0 0 0 0 0 25 22 64 24 38 58 84
2021/2022336 26 35 2 7 6 6 24 20 4 50 114 42
2022/2023458 45 56 6 59 57 101 1 36 63 6 20 8
2023/2024278 23 9 17 9 52 99 2 12 20 11 1 23
2024/2025871 18 48 29 51 74 40 71 47 117 72 116 188
2025/20261.259 234 158 104 221 362 180 0 0 0 0 0 0
Totale 4.580